, and 27 were tested in vitro. However, no compounds showed potent inhibitory activity.
Results and Discussion
In this paper, 16 compounds (viz. 1, 3-6, 8, 9, 12-14, 20, 21, 24, 26, 27 , and 29) were obtained from seeds of the Thai X. moluccensis, whereas 13 compounds (viz. 2, 7, 10, 11, 15-19, 22, 23, 25, and 28) were isolated from those of the Indian X. moluccensis.
Compound 1 was obtained as a colorless crystal. The molecular formula of 1 was established from the positive HRESIMS ion peak at m/z 615.2785 (calcd. for [M + H] + , 615.2800) to be C33H42O11, implying thirteen degrees of unsaturation. According to the 1 H and 13 C NMR spectroscopic data (Tables 1 and 2 ), five elements of unsaturation were due to four ester groups, a keto carbonyl function, and three carbon-carbon double bonds; thus, the molecule was pentacyclic. The 1 H and 13 C NMR spectroscopic data (Tables 1 and 2) showed the presence of a β-substituted furan ring [δH 7.52 br d (J 
Compound 1 was obtained as a colorless crystal. The molecular formula of 1 was established from the positive HRESIMS ion peak at m/z 615.2785 (calcd. for [M + H] + , 615.2800) to be C 33 H 42 O 11 , implying thirteen degrees of unsaturation. According to the 1 H and 13 C NMR spectroscopic data (Tables 1 and 2 ), five elements of unsaturation were due to four ester groups, a keto carbonyl function, and three carbon-carbon double bonds; thus, the molecule was pentacyclic. The 1 H and 13 C NMR spectroscopic data (Tables 1 and 2) showed the presence of a β-substituted furan ring [δ H 7.52 3 -31) , and a keto function (δ C 216.7 qC), indicating a mexicanolide-type limonoid for 1. = 0.8 Hz H-21), 6 .45 br d (J = 1.2 Hz H-22), 7.44 t (J = 1.6 Hz H-23)], four tertiary methyl groups (δH 1.27 s H3-19, 1.04 s H3-29, 1.05 s H3-18, 0.84 s H3-28) , a methoxy (δH 3.73 s H3-31), and a keto function (δC 216.7 qC), indicating a mexicanolide-type limonoid for 1.
The NMR spectroscopic data of 1 (Tables 1 and 2 ) were similar to those of khayalenoid H [19] , except for the replacement of the 3-O-acetyl group in khayalenoid H by an isobutyryloxy group [δH 2.64 m 1H, 1.22 d (J = 7.2 Hz 3H), 1.24 d (J = 7.2 Hz 3H) ; δC 175.9 qC, 34.5 CH, 19.9 CH3, 18.4 CH3 ] in 1. The presence of the isobutyryloxy group was corroborated by 1 H-1 H COSY correlations between H3-34/H-33 and H3-35/H-33. The significant HMBC correlation from H-3 (δH 4.97 s) to the carbonyl carbon (δC 175.9 qC) of the isobutyryloxy group placed it at C-3 ( Figure 2a) .
The relative configuration of 1 was established by diagnostic NOE interactions (Figure 2b ). Those between H-17/H-11β, H-17/H-12β, H-17/H-5, and H-5/H3-28 revealed their cofacial relationship, and were arbitrarily assigned as the β-oriented H-17 and H-5. NOE interactions between H-9/H-12α, H-9/H3-19, H3-18/H-12α, H-3/H3-29, and 2-OH/H3-29 assigned the α-orientation for H-9, H3-18, H3-19, H-3, and 2-OH. In order to establish the absolute configuration of 1, single-crystal X-ray diffraction analysis with Cu Kα radiation (Flack parameter of −0.06 (10) , Flack x of −0.14 (11) , and Hooft y of −0.04 (3) ; suitable crystals of 1 were obtained from acetone/methanol (1:2) at room temperature) was employed, which unequivocally assigned the absolute configuration of 1 as 2R,3S,5S,6R,9S,10R,13R,17R. The computer-generated perspective drawing of the X-ray structure of 1 is shown in Figure 3 . Therefore, the absolute configuration of 1named xylomolin A1was assigned as shown (Figure 2a ). In order to establish the absolute configuration of 1, single-crystal X-ray diffraction analysis with Cu Kα radiation (Flack parameter of −0.06 (10) , Flack x of −0.14 (11) , and Hooft y of −0.04 (3) ; suitable crystals of 1 were obtained from acetone/methanol (1:2) at room temperature) was employed, which unequivocally assigned the absolute configuration of 1 as 2R,3S,5S,6R,9S,10R,13R,17R. The computer-generated perspective drawing of the X-ray structure of 1 is shown in Figure 3 . Therefore, the absolute configuration of 1 named xylomolin A 1 was assigned as shown (Figure 2a The NMR spectroscopic data of 1 (Tables 1 and 2 ) were similar to those of khayalenoid H [19] , except for the replacement of the 3-O-acetyl group in khayalenoid H by an isobutyryloxy group [δH 2.64 m 1H, 1.22 d (J = 7.2 Hz 3H), 1.24 d (J = 7.2 Hz 3H) ; δC 175.9 qC, 34.5 CH, 19.9 CH3, 18.4 CH3 ] in 1. The presence of the isobutyryloxy group was corroborated by 1 H-1 H COSY correlations between H3-34/H-33 and H3-35/H-33. The significant HMBC correlation from H-3 (δH 4.97 s) to the carbonyl carbon (δC 175.9 qC) of the isobutyryloxy group placed it at C-3 ( Figure 2a) .
The relative configuration of 1 was established by diagnostic NOE interactions (Figure 2b ). Those between H-17/H-11β, H-17/H-12β, H-17/H-5, and H-5/H3-28 revealed their cofacial relationship, and were arbitrarily assigned as the β-oriented H-17 and H-5. NOE interactions between H-9/H-12α, H-9/H3-19, H3-18/H-12α, H-3/H3-29, and 2-OH/H3-29 assigned the α-orientation for H-9, H3-18, H3-19, H-3, and 2-OH. In order to establish the absolute configuration of 1, single-crystal X-ray diffraction analysis with Cu Kα radiation (Flack parameter of −0.06 (10) , Flack x of −0.14 (11) , and Hooft y of −0.04 (3) ; suitable crystals of 1 were obtained from acetone/methanol (1:2) at room temperature) was employed, which unequivocally assigned the absolute configuration of 1 as 2R,3S,5S,6R,9S,10R,13R,17R. The computer-generated perspective drawing of the X-ray structure of 1 is shown in Figure 3 . Therefore, the absolute configuration of 1named xylomolin A1was assigned as shown (Figure 2a) . Oak Ridge Thermal-Ellipsoid Plot Program (ORTEP) illustration of the X-ray structure of compound 1. Ellipsoids are given at the 30% probability level. (20.8, 2.8) 3.47 dt (20.8, 3.2) 3.64 dd (20.8, 3.2) 5.23 d (2.4) 3.65 dd (20.8, 3.2) 3.51 dt (20.8, 3.2) 3.52 dt (20.8, 2.8) (Tables 1 and 2) , except for the replacement of the 3-O-isobutyryl moiety and the 6-O-acetyl group in 1 by a 3-O-propionyl moiety (δ H 2.45 m 1H, 2.43 m 1H, 1.20 t (J = 7.6 Hz 3H); δ C 173.3 qC, 28.0 CH 2 , 9.4 CH 3 ) and a 6-OH group in 2, respectively. The presence of a 3-O-propionyl moiety was confirmed by 1 H-1 H COSY correlations between H 3 -34/H 2 -33 and HMBC cross-peaks between H 3 -34/C-33, H 3 -34/C-32, H 2 -33/C-32, and H-3/C-32. The relative configuration of 2 (except for that of C-6) was determined to be the same as that of 1 by NOE interactions between H-17/H-15β, H-15β/H-30β, H-17/H-12β, H-17/H-11β, H-11β/H-5, H-17/H-5, and H-5/H 3 -28, and those between H-9/H 3 -19, H 3 -19/H 3 -29, H 3 -29/H-3, and H 3 -18/H-15α . Thus, the structure of 2-named xylomolin A 2 -was assigned as shown in Figure 1 .
Compound 3 gave the molecular formula C 32 H 42 O 11 as established by the HRESIMS ion peak at m/z 625.2620 (calcd. for [M + Na] + , 625.2619). The NMR spectroscopic data of 3 (Tables 1 and 2 ) were similar to those of moluccensin S [20] , except for the presence of an additional 30-OH group, which was supported by the downshifted C-30 signal (δ C 73.0 CH in 3, whereas δ C 44.6 CH 2 in moluccensin S) and HMBC correlations from the proton of 30-OH to C-30, C-2, and C-8. NOE interactions between H-17/H-12β, H-17/H-11β, H-5/H-12β, H-5/H-17, H-5/H 3 -28, and H-5/H-30 revealed the β-orientation for H -5, H-17, H-30, and H 3 -28 , and the corresponding 30α-OH. Similarly, those between H-3/2-OH, H 3 -29/2-OH, H-9/H 3 -19, H 3 -29/H 3 -19 , and H 3 -18/H-11α assigned the α-orientation for H -3, H-9, H 3 -18, H 3 -19, H 3 -29 , and 2-OH. Thus, the structure of 3-named xylomolin A 3 -was determined to be 30α-hydroxy-moluccensin S.
Compound 4 provided the molecular formula of C 34 H 44 O 13 as determined from the positive HRESIMS ion peak at m/z 683.2675 (calcd. for [M + Na] + , 683.2674). The 1 H and 13 C NMR spectroscopic data of 4 resembled those of 3 (Tables 1 and 2), the difference being the presence of a 15-OH function (δ H 3.66 br s) and a 6-acetoxy group (δ H 2.18 s 3H; δ C 169.8 qC, 21.0 CH 3 ) in 4. The existence of a 15-OH function was corroborated by the downshifted C-15 signal (δ C 65.4 CH in 4, whereas δ C 32.8 CH 2 in 3) and HMBC correlations from the proton of 15-OH to C-14, C-15, and C-16. The HMBC correlation from H-6 to the carbonyl carbon (C-37) of the acetoxy group placed it at C-6. The relative configuration of 4 (except that of C-15) was assigned as the same as that of 3 on the basis of NOE interactions. Those between H-17/H-15 and H-5/H-30 assigned the β-oriented H-15 and H-30, and the corresponding 15α-OH group. Consequently, the structure of 4-named xylomolin A 4 -was identified as 15α-hydroxy-6-acetoxy-xylomolin A 3 .
The molecular formula of 5 was determined to be C 31 H 38 O 12 by the positive HRESIMS ion peak at m/z 625.2252 (calcd. for [M + Na] + , 625.2255). The 1 H and 13 C NMR spectroscopic data of 5 (Tables 1 and 2) were closely related to those of khayalenoid H, the difference being the existence of a 30-OH function, which was supported by the downshifted C-30 signal (δ C 72.9 CH in 5, whereas δ C 44.4 CH 2 in khayalenoid H). HMBC correlations from the proton of 30-OH (δ H 2.67 br s) to C-30 and C-8 demonstrated the above deduction. The NOE interaction between H-5/H-30 assigned the β-oriented H-30 and the corresponding 30α-OH. Thus, the structure of 5-named xylomolin A 5 -was assigned as 30α-hydroxy-khayalenoid H.
Compound 6 was isolated as a white and amorphous powder. Its molecular formula was determined to be C 31 H 38 O 11 from the positive HRESIMS ion peak at m/z 609.2311 (calcd. for [M + Na] + , 609.2306). The 1 H and 13 C NMR spectroscopic data of 6 (Tables 1 and 2) closely resembled those of khayalenoid H [19] , except for the replacement of the 2-OH function and the 6-O-acetyl group in khayalenoid H by a 2-O-acetyl (δ H 2.13 s 3H; δ C 169.1 qC, 21.8 CH 3 ) and a 6-OH group (δ H 2.80 br s) in 6, respectively. HMBC correlations from the proton of the 6-OH group to C-5, C-6,and C-7 placed it at C-6. The presence of the 2-O-acetyl group in 6 was corroborated by the downshifted C-2 in 6 (δ C 86.5 qC in 6, whereas δ C 77.9 qC in khayalenoid H). HMBC correlations from H 2 -30 and H-3 to C-2 confirmed the above deduction. The relative configuration of 6 was determined to be the same as that of khayalenoid H based on diagnostic NOE interactions between H-17/H-15β, H-17/H-12β, H-17/H-5, and H-5/H 3 -28 and those between H-9/H 3 -19, H 3 -19/H 3 -29, and H 3 -18/H-15α . Therefore, the structure of 6-named xylomolin A 6 -was determined to be 2-O-acetyl-6-O-deacetyl-khayalenoid H.
The molecular formula of 7 was determined to be C 31 H 38 O 10 by the positive HRESIMS ion peak at m/z 593.2358 (calcd. for [M + Na] + , 593.2357). The 1 H and 13 C NMR spectroscopic data of 7 (Tables 1 and 2) were closely related to those of 6, except for the absence of the 6-OH group, which was corroborated by the upshifted CH 2 -6 signal (δ H 2.32 dd (J = 16.5, 1.6 Hz), 2.42 dd (J = 16.5, 10.7 Hz), δ C 33.3) in 7. 1 H-1 H COSY correlations between H 2 -6/H-5 and HMBC cross-peaks from H 2 -6 and C-5 and C-7 confirmed the above result. The analysis of diagnostic NOE interactions revealed that 7 possessed the same relative configuration as that of 6. Therefore, the structure of 7-named xylomolin A 7 -was assigned as 6-dehydroxy-xylomolin A 6 .
Compound 8 was isolated as a white and amorphous powder. It had a molecular formula of C 31 H 36 O 11 as deduced from the positive HRESIMS ion peak at m/z 607.2151 (calcd. for [M + Na] + , 607.2150). The 1 H and 13 C NMR spectroscopic data of 8 (Tables 3 and 4 ) were similar to those of heytrijunolide E [21] with ∆ 8,9 and ∆ 14,15 conjugated double bonds, except for the absence of the 15-OH group and the presence of an acetoxy group at C-3 in 8. The absence of the 15-OH group was confirmed by the upshifted C-15 signal (δ C 111.6 qC in 8, whereas δ C 134.7 qC in heytrijunolide E) and HMBC correlations between H-15/C-14, H-15/C-16, H-15/C-8, and H-15/C-13. The HMBC correlation from H-3 (δ H 5.51 s) to the carbonyl carbon (δ C 170.2 qC) of the acetoxy group placed it at C-3. The relative configuration of 8 was established to be the same as that of heytrijunolide E based on diagnostic NOE interactions between H 3 -28/H-5, H-5/H-11β, H-12β/H-17, H 3 -29/H-3, H-12α/H 3 -18, and H-11α/H 3 -19 . Therefore, the structure of 8-named xylomolin B 1 -was assigned as 15-dehydroxy-3β-acetoxy-heytrijunolide E. Compound 9 provided the molecular formula C 29 H 34 O 9 as established by the positive HRESIMS ion peak at m/z 527.2273 (calcd. for [M + H] + , 527.2276). The 1 H and 13 C NMR spectroscopic data of 9 (Tables 3 and 4) were similar to those of heytrijunolide E [21] , the difference being the absence of the 2-OH and 15-OH groups in 9, which was corroborated by the upshifted C-15 (δ C 110.6 CH in 9, whereas δ C 134.7 qC in heytrijunolide E) and C-2 (δ C 50.5 CH in 9, whereas δ C 78.2 qC in heytrijunolide E) signals. A proton (δ H 3.02 t (J = 6.0 Hz)) exhibiting 1 H-1 H COSY correlations to H-3 and H-30 and HMBC cross-peaks to C-1, C-3, C-4, and C-30 was assigned as H-2. The existence of H-15 (δ H 5.89 s) was further confirmed by its HMBC correlations to C-8, C-13, C-14, and C-16. The relative configuration of 9 was determined to be the same as that of heytrijunolide E based on diagnostic NOE interactions between H 3 -28/H-5, H-5/H-11β, H-12β/H-17, H 3 -29/H-3, H-12α/H 3 -18, and H-11α/H 3 -19. Thus, the structure of 9-named xylomolin B 2 -was assigned as 2,15-dedihydroxy-heytrijunolide E.
Compound 10 (Tables 3 and 4) closely resembled those of moluccensin U [20] , except for the replacement of the 3-O-(2-methyl)butyryl group in moluccensin U by an acetoxy group (δ H 2.22 s 3H; δ C 169.9 qC, 20.7 CH 3 ) in 10. The significant HMBC cross-peak from H-3 (δ H 4.83 s) to the carbonyl carbon of the above acetoxy group placed it at C-3. NOE interactions between H-11β/H-17, H-12β/H-17, H-11β/H-5, H-5/H 3 -28, H-9/H 3 -18, H-9/H 3 -19, and H 3 -29/H-3 revealed the same relative configuration of 10 as that of moluccensin U. Therefore, the structure of 10-named xylomolin C 1 -was assigned as 3-O-acetyl-3-de(2-methyl) butyryloxy-moluccensin U.
Compound 11 afforded the molecular formula C 32 H 40 O 9 as established by the positive HRESIMS ion peak at m/z 591.2570 (calcd. for [M + Na] 3 -18, H 3 -19, and H-3 . Thus, the structure of 11-named xylomolin C 2 -was assigned as 3-O-(2-methyl)butyryl-3-deisobutyryloxy-swietmanin G.
Compound 12 had the molecular formula C 32 H 42 O 11 as determined from the positive HRESIMS ion peak at m/z 625.2612 (calcd. for [M + Na] + , 625.2619). The 1 H and 13 C NMR spectroscopic data of 12 (Tables 3 and 4 ) were similar to those of moluccensin U [20] , except for the absence of the ∆ 8,30 double bond and the presence of an 8-OH group. This finding was verified by the upshifted C-8 (δ C 71.3 qC) and C-30 (δ C 45.9 CH 2 ) signals as compared with those (δ C 134.5 qC and 133.6 CH) of moluccensin U, respectively. The presence of the 8-OH group was confirmed by HMBC correlations from its proton to C-8, C-9, and C-30. NOE interactions between 8-OH/H-9 and 8-OH/H 3 -18 assigned the α-orientation for the 8-OH group. The relative configuration of 12 (except that of C-8) was established to be identical to that of moluccensin U based on diagnostic NOE interactions between H-12β/H-17, H-5/H 3 -28, H-9/H 3 -19, and H 3 -29/H-3. Thus, the structure of 12-named xylomolin D-was assigned as 8,30-dihydrogen-8α-hydroxy-moluccensin U.
Compound 13 was obtained as an amorphous white power. The molecular formula was determined to be C 31 H 38 O 12 by the positive HRESIMS ion peak at m/z 625.2250 (calcd. for [M + Na] + , 625.2255). The 1 H and 13 C NMR spectroscopic data of 13 (Tables 3 and 4) were similar to those of 8, except for the replacement of ∆ 8,9 and ∆ 14,15 conjugated double bonds in 8 by a ∆ 8,30 double bond (δ C 138.8 qC C-8, 130.2 CH C-30) in 13, and the presence of an additional 14-OH group. HMBC correlations between H 2 -15/C-14, H 2 -15/C-16, H 2 -15/C-13, H-30/C-14, H-30/C-9, and H-9/C-8 demonstrated the above deduction. In order to establish the relative configuration of the 14-OH group in 13, two possible 3D structures with a 14α-OH and 14β-OH groups, respectively, were simulated by using the ChemBio3D software (Figure 4 ). When the 14-OH group occupies α-orientation, the space distance between H-5/H-17 is around 2.4 Å (Figure 4a ), implying the presence of a strong NOE interaction between these protons. On the contrary, when the 14-OH group occupies the β-orientation, the space distance between H-5/H-17 is around 5.8 Å (Figure 4b ), indicating the absence of a NOE interaction between these protons. Quite evidently, the NOE interaction between H-5/H-17 could be utilized as an effective criterion to resolve the relative configuration of the 14-OH group. Thus, the orientation of the 14-OH group in 13 was assigned as α based on the strong NOE interaction between H-5/H-17. Furthermore, the relative configuration of the whole molecule of 13 (except that of C-14) was determined to be the same as that of 8 on the basis of NOE interactions between H 3 -28/H-5, H-5/H-11β, H-12β/H-17, H 3 -29/H-3, H-12α/H 3 -18, and H-11α/H 3 -19. Thus, the structure of 13-named xylomolin E-was assigned as depicted.
Compounds 2-13 are analogues of 1. From the point of view of biogenetic origins, these mexicanolides should possess the same absolute configurations of carbon skeletons as that of 1. The absolute sterostructures of 2-13 are shown as in Figure 1 .
The molecular formula of 14 was determined to be C 33 H 42 O 13 by the positive HRESIMS ion peak at m/z 669.2521 (calcd. for [M + Na] + , 669.2518). The NMR spectroscopic data of 14 (Tables 3  and 4 ) were similar to those of xylorumphiin H [23] , being a mexicanolide containing a C1-O-C8 bridge, except for the presence of an additional ∆ 14,15 double bond (δ H 6.08 s 1H; δ C 158.3 qC, 118.4 CH) and an additional 6-OH function (δ H 2.93 s) in 14. The existence of the ∆ 14,15 double bond was corroborated by HMBC correlations between H 3 -18/C-14, H-15/C-8, and H-15/C-16. The downshifted C-6 signal (δ C 71.7 CH in 14, whereas δ C 32.3 CH 2 in xylorumphiin H), along with HMBC cross-peaks from H-6 to C-5 and C-7, supported the location of a hydroxy group at C-6. Similar NOE interactions of 14 as those of xylorumphiin H suggested that both mexicanolides possessed the same relative configuration. Thus, the structure of 14-named xylomolin F-was assigned as 6-hydroxy-14,15-dedihydrogen-xylorumphiin H. Mar. Drugs 2018, 16, 38 9 of 28 (except that of C-14) was determined to be the same as that of 8 on the basis of NOE interactions between H3-28/H-5, H-5/H-11β, H-12β/H-17, H3-29/H-3, H-12α/H3-18, and H-11α/H3-19. Thus, the structure of 13-named xylomolin E-was assigned as depicted.
(a) (b) Compounds 2-13 are analogues of 1. From the point of view of biogenetic origins, these mexicanolides should possess the same absolute configurations of carbon skeletons as that of 1. The absolute sterostructures of 2-13 are shown as in Figure 1 .
The molecular formula of 14 was determined to be C33H42O13 by the positive HRESIMS ion peak at m/z 669.2521 (calcd. for [M + Na] + , 669.2518). The NMR spectroscopic data of 14 (Tables 3 and 4) were similar to those of xylorumphiin H [23] , being a mexicanolide containing a C1-O-C8 bridge, except for the presence of an additional Δ 14,15 double bond (δH 6.08 s 1H; δC 158.3 qC, 118.4 CH) and an additional 6-OH function (δH 2.93 s) in 14. The existence of the Δ 14,15 double bond was corroborated by HMBC correlations between H3-18/C-14, H-15/C-8, and H-15/C-16. The downshifted C-6 signal (δC 71.7 CH in 14, whereas δC 32.3 CH2 in xylorumphiin H), along with HMBC cross-peaks from H-6 to C-5 and C-7, supported the location of a hydroxy group at C-6. Similar NOE interactions of 14 as those of xylorumphiin H suggested that both mexicanolides possessed the same relative configuration. Thus, the structure of 14-named xylomolin F-was assigned as 6-hydroxy-14,15-dedihydrogen-xylorumphiin H.
The molecular formula of 15 was established by the positive HRESIMS ion peak at m/z 587.2494 (calcd. for [M + H] + , 587.2492) to be C31H38O11, implying thirteen degrees of unsaturation. According to the NMR spectroscopic data of 15 (Tables 5 and 6 ), seven elements of unsaturation were due to three carbon-carbon double bonds, one carbonyl group, and three ester functionalities; thus, 15 should be hexacyclic. The NMR spectroscopic data of 15 resembled those of thaixylomolin L [18] , being a khayanolide isolated from seeds of the Thai X. moluccensis, except for the presence of an additional 6-OH group in 15. (Tables 5 and 6 ), seven elements of unsaturation were due to three carbon-carbon double bonds, one carbonyl group, and three ester functionalities; thus, 15 should be hexacyclic. The NMR spectroscopic data of 15 resembled those of thaixylomolin L [18] , being a khayanolide isolated from seeds of the Thai X. moluccensis, except for the presence of an additional 6-OH group in 15. Strong 3 J HMBC correlations from H 2 -29 to C-30 further confirmed a khayanolide for 15 instead of a phragmalin, which should exhibit weak 4 J HMBC correlations between H 2 -29/C-30. HMBC cross-peaks from an active proton (δ H 2.91 d (J = 3.4 Hz)) to C-5 (δ C 45.4, CH), C-6 (δ C 72.0, CH), and C-7 (δ C 175.3, qC) (Figure 5a ) revealed the existence of a 6-OH group in 15. [18] showed that 15 had the same 1R,3S,4R,5S,9R,10S,13R,17R,30S-absolute configuration as that of thaixylomolin L (Figure 6a) . Thus, the structure of 15-named xylomolin G 1 -was assigned as depicted.
Mar. Drugs 2018, 16, 38 11 of 28 The relative configuration of 15 was assigned by analysis of NOE interactions (Figure 5b) . Those between H-17/H-12β, H-17/H-15β, H-17/H-11β, and H-11β/H-5 revealed their cofacial relationship and were assigned as β-oriented. In turn, NOE interactions between H3-18/H-15α, H-9/H3-19, H3-19/1-OH, and H-34/Hpro-R-29 indicated the α-orientation for H-9, H3-18, H3-19, 1-OH, and 30-OEt. The NOE interaction between H-3/Hpro-R-29 established the 3α-H and the corresponding 3β-acetoxy function. Therefore, the relative configuration of 15 was determined. Comparison of the electronic circular dichroism (ECD) spectrum of 15 with that of thaixylomolin L [18] showed that 15 had the same 1R,3S,4R,5S,9R,10S,13R,17R,30S-absolute configuration as that of thaixylomolin L (Figure 6a) . Thus, the structure of 15-named xylomolin G1-was assigned as depicted. The relative configuration of 15 was assigned by analysis of NOE interactions (Figure 5b) . Those between H-17/H-12β, H-17/H-15β, H-17/H-11β, and H-11β/H-5 revealed their cofacial relationship and were assigned as β-oriented. In turn, NOE interactions between H3-18/H-15α, H-9/H3-19, H3-19/1-OH, and H-34/Hpro-R-29 indicated the α-orientation for H-9, H3-18, H3-19, 1-OH, and 30-OEt. The NOE interaction between H-3/Hpro-R-29 established the 3α-H and the corresponding 3β-acetoxy function. Therefore, the relative configuration of 15 was determined. Comparison of the electronic circular dichroism (ECD) spectrum of 15 with that of thaixylomolin L [18] showed that 15 had the same 1R,3S,4R,5S,9R,10S,13R,17R,30S-absolute configuration as that of thaixylomolin L (Figure 6a) . Thus, the structure of 15-named xylomolin G1-was assigned as depicted. -34/C-32, and H 3 -35/C-32. The significant HMBC cross-peak from H-3 to the carbonyl carbon (C-32) of the isobutyryloxy group confirmed its location at C-3. NOE interactions between H-17/H-12β, H-17/H-15β, H-17/H-11β, H-11β/H-5, H-17/H-5, H-5/H 3 -28, H-3/H pro -R -29, H-15α/H 3 -18, H 3 -18/H-9, H-9/H 3 -19, and 1-OH/H-9 indicated the same relative configuration of 16 as that of 15. Comparison of the ECD spectrum of 16 with that of thaixylomolin L concluded that 16 had the same 1R,3S,4R,5S,9R,10S,13R,17R,30S-absolute configuration as that of thaixylomolin L (Figure 6a) . Thus, the structure of 16-named xylomolin G 2 -was assigned as 3-O-isobutyryl-3-deacetoxy-xylomolin G 1 .
Compound 17 was isolated as an amorphous yellow solid. Its molecular formula was determined to be C 29 The similarities between the NMR spectroscopic data of 17 (Tables 5 and 6 ) and 15 revealed their close structural resemblance, except for the absence of the ethoxyl group at C-30, which was confirmed by the upshifted C-30 signal (δ C 63.0 CH in 17, whereas δ C 92.2 qC in 15) and HMBC cross-peaks between H-30/C-1, H-30/C-2, H-30/C-8, and H-30/C-10. The relative configuration of 17 was determined to be identical to that of 15 by analysis of NOE interactions. Comparison of ECD spectra of 17 and 15 concluded that both compounds had the same 1R,3S,4R,5S,9R,10S,13R,17R,30S-absolute configuration (Figure 6a) . Thus, the structure of 17-named xylomolin G 3 -was assigned as 30-deethoxyl-xylomolin G 1 .
Compound 18 provided the molecular formula C 31 H 38 O 9 as established by the positive HRESIMS ion peak at m/z 555.2593 (calcd. for [M + H] + , 555.2594). The NMR spectroscopic data of 18 (Tables 5  and 6 ) were similar to those of 15, the difference being the absence of the 30-ethoxyl group and the 6-OH function in 18. The upshifted C-30 (δ C 63.4 CH in 18, whereas δ C 92.2 qC in 15) and C-6 (δ C 34.2 CH 2 in 18, whereas δ C 72.1 CH in 15) signals and HMBC cross-peaks between H-30/C-1, H-30/C-2, H-30/C-8, H-30/C-10, H-6/C-5, and H-6/C-7 supported the above deduction. The relative and absolute configurations of 18 were determined to be the same as that of 15 by analysis of their NOE interactions and ECD spectra (Figure 6a) . Thus, the structure of 18-named xylomolin G 4 -was concluded to be 30-deethoxyl-6-dehydroxy-xylomolin G 1 .
Compound 19 -36/C-34, and H 3 -35/C-33. The significant HMBC cross-peak from H-3 to the carbonyl carbon (C-32) of the above 2-methylbutyryloxy group assigned its location at C-3. The relative and absolute configurations of 19 were determined to be the same as those of 18 by analysis of their NOE interactions and ECD spectra (Figure 6a) . Thus, the structure of 19-named xylomolin G 5 -was assigned as 3-O-(2-methyl)butyryl-3-deisobutyryloxy-xylomolin G 4 .
Compound 20 was isolated as an amorphous white powder. Its molecular formula was determined to be C 33 Its location at C-1 was corroborated by the downshifted C-1 signal (δ C 92.6 qC in 20, whereas δ C 84.5 qC in 15). The relative configuration of 20 was established by NOE interactions, in which those between H-17/H-12β, H-12β/H-5, H-5/H 3 -28 assigned the β-orientation for H-17, H-5, H 3 -28, whereas those between H-11α/H 3 -18, H 3 -18/8-OH, 8-OH/H-9, H pro-R -29/H-3, H-9/H 3 -19, and H-3/30-OH concluded the α-orientation for H [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] , and 30-OH. Thus, the structure of 20-named xylomolin H-was assigned as depicted.
Compound 21 afforded the molecular formula C 32 H 38 O 11 as deduced from the positive HRESIMS ion peak at m/z 621.2304 (calcd. for [M + Na] + , 621.2306). The NMR spectroscopic data of 21 (Tables 5 and 6 ) were similar to those of thaixylomolin H [18] , except for the presence of an additional (Figure 6b ), concluding that 21 had the same 1R,2R,4R,5R,10S,13R,17R,30R-absolute configuration as that of thaixylomolin H. Thus, the structure of 21-named xylomolin I-was identified as 6-hydroxy-2-O-(2-methyl)butyryl-2-deacetoxy-thaixylomolin H.
Compound 22 (Figure 7a ). The relative configuration of 22 was assigned by NOE interactions (Figure 7b) . Those between H-17/H-12β, H-12β/H 3 -19, and H 3 -19/H-5 revealed their cofacial relationship and were determined as β-oriented, whereas those between H-3/H-9, H pro-R -29/H-3, and H-12α/H 3 -18 indicated the α-orientation for H-3, H-9, and H 3 -18, and the corresponding 3β-acetoxy function. The ECD spectrum of 22 was nicely matched with that of trangmolin F (Figure 8a) , concluding that the absolute configuration of 22 was the same as that of trangmolin F. Thus, the structure of 22-named xylomolin J 1 -was assigned as 3-O-acetyl-3-deisobutyryloxy-trangmolin F. and 6) were similar to those of thaixylomolin H [18] , except for the presence of an additional 6-OH group (δH 3.19 s) and the replacement of the 2-acetoxy group by a 2-methylbutyryloxy moiety (δH 2.42 m 1H, 1.73 m 1H, 1.48 m 1H, 0.97 t (J = 7.6 Hz 3H), 1.22 d (J = 7.2 Hz 3H); δC 176.0 qC, 41. 3 CH, 26.5 CH2, 11.7 CH3, 17.2 CH3) in 21. The presence of the 6-OH group was supported by the downshifted C-6 signal (δC 71.0 CH in 21, whereas δC 31.6 CH2 in thaixylomolin H), the 1 H-1 H COSY cross-peak between H-5/H-6, and HMBC correlations between H-6/C-5 and H-6/C-7. The existence of the 2-methylbutyryloxy group was corroborated by 1 (Figure 6b ), concluding that 21 had the same 1R,2R,4R,5R,10S,13R,17R,30R-absolute configuration as that of thaixylomolin H. Thus, the structure of 21-named xylomolin I-was identified as 6-hydroxy-2-O-(2-methyl)butyryl-2-deacetoxy-thaixylomolin H.
Compound 22 (Figure 7a ). The relative configuration of 22 was assigned by NOE interactions (Figure 7b) . Those between H-17/H-12β, H-12β/H3-19, and H3-19/H-5 revealed their cofacial relationship and were determined as β-oriented, whereas those between H-3/H-9, Hpro-R-29/H-3, and H-12α/H3-18 indicated the α-orientation for H-3, H-9, and H3-18, and the corresponding 3β-acetoxy function. The ECD spectrum of 22 was nicely matched with that of trangmolin F (Figure 8a) , concluding that the absolute configuration of 22 was the same as that of trangmolin F. Thus, the structure of 22-named xylomolin J1-was assigned as 3-O-acetyl-3-deisobutyryloxy-trangmolin F. between H-33/C-32, H-34/C-32, and H 3 -36/C-32. The HMBC correlation from H-3 to the carbonyl carbon (C-32) of the above 2-methylbutyryloxy group placed it at C-3. The relative configuration of 23 was confirmed to be the same as that of 22 by analysis of NOE interactions. Comparison of ECD spectra of compounds 23, 22, and trangmolin F (Figure 8a ) revealed that these compounds had the same absolute configuration. The absolute configuration of C-6 was further determined by the modified Mosher α-methoxy-α-(trifluoromethyl)phenylacetyl (MTPA) ester method [24] . The ∆δ values of H-5, H 3 -19, and H 3 -29 were positive, while that of H 3 -31 was negative (Figure 8b ). This regular arrangement concluded the R-absolute configuration for C-6. Finally, the absolute configuration of 23-named xylomolin J 2 -was unequivocally established as 3S,4R,5S,6R,9S,10R,13R,17R. 40.7 CH, 26.6 CH2, 11.5 CH3, 16.4 CH3) in 23. The presence of the 2-methylbutyryloxy group was further evidenced by , and H3-36/C-32. The HMBC correlation from H-3 to the carbonyl carbon (C-32) of the above 2-methylbutyryloxy group placed it at C-3. The relative configuration of 23 was confirmed to be the same as that of 22 by analysis of NOE interactions. Comparison of ECD spectra of compounds 23, 22, and trangmolin F (Figure 8a ) revealed that these compounds had the same absolute configuration. The absolute configuration of C-6 was further determined by the modified Mosher α-methoxy-α-(trifluoromethyl)phenylacetyl (MTPA) ester method [24] . The ∆δ values of H-5, H3-19, and H3-29 were positive, while that of H3-31 was negative (Figure 8b ). This regular arrangement concluded the Rabsolute configuration for C-6. Finally, the absolute configuration of 23-named xylomolin J2-was unequivocally established as 3S,4R,5S,6R,9S,10R,13R,17R. Compound 24 had the molecular formula C32H38O11 as determined from the positive HRESIMS ion peak at m/z 621.2306 (calcd. for [M + Na] + , 621.2306). The NMR spectroscopic data of 24 (Tables 7  and 8 ) were similar to those of moluccensin I [25] , except for the presence of an additional 6-OH group (δH 3.12 br s) and the replacement of the 1-O-isobutyryl group in moluccensin I by a 1-OH function (δH 2.81 s) in 24. The downshifted C-6 signal (δC 71.5 CH in 24, whereas δC 33.2 CH2 in moluccensin I) and HMBC correlations from the active proton (δH 3.12 br s) to C-5, C-6, and C-7 revealed the presence of the 6-OH group (Figure 9a) . The existence of the 1-OH function was confirmed by the upshifted C-1 signal (δC 85.8 qC in 24, whereas δC 90.8 qC in moluccensin I) and strong HMBC cross-peaks from the active proton (δH 2.81 s) to C-1, C-2, and C-10 ( Figure 9a ). The relative configuration of 24 was identified as the same as that of moluccensin I based on NOE interactions between H-17/H-12β, , and 2-OH/Hpro-R-29 ( Figure 9b) . Therefore, the structure of 24-named xylomolin K1-was assigned as 6-hydroxy-1-O-deisobutyryl-moluccensin I. Compound 24 had the molecular formula C 32 H 38 O 11 as determined from the positive HRESIMS ion peak at m/z 621.2306 (calcd. for [M + Na] + , 621.2306). The NMR spectroscopic data of 24 (Tables 7  and 8 ) were similar to those of moluccensin I [25] , except for the presence of an additional 6-OH group (δ H 3.12 br s) and the replacement of the 1-O-isobutyryl group in moluccensin I by a 1-OH function (δ H 2.81 s) in 24. The downshifted C-6 signal (δ C 71.5 CH in 24, whereas δ C 33.2 CH 2 in moluccensin I) and HMBC correlations from the active proton (δ H 3.12 br s) to C-5, C-6, and C-7 revealed the presence of the 6-OH group (Figure 9a) . The existence of the 1-OH function was confirmed by the upshifted C-1 signal (δ C 85.8 qC in 24, whereas δ C 90.8 qC in moluccensin I) and strong HMBC cross-peaks from the active proton (δ H 2.81 s) to C-1, C-2, and C-10 ( Figure 9a ). The relative configuration of 24 was identified as the same as that of moluccensin I based on NOE interactions between H-17/H-12β, H-5/H-11β, H-5/H-28, H 3 -18/H-11α, H 3 -19/H pro-S -29, H-3/H pro-R -29, and 2-OH/H pro-R -29 ( Figure 9b) . Therefore, the structure of 24-named xylomolin K 1 -was assigned as 6-hydroxy-1-O-deisobutyryl-moluccensin I. Compound 26 was obtained as an amorphous white powder. Its molecular formula was determined to be C33H38O14 by the positive HRESIMS ion peak at m/z 681.2149 (calcd. for [M + Na] + , 681.2154). The NMR spectroscopic data of 26 (Tables 7 and 8 ) resembled those of 2-O-acetyl-2-dehydroxy-12-deacetylxyloccensin U [18] , being a phragmalin 8,9,30-ortho ester isolated from X. moluccensis, except for the presence of an additional 6-OH group and the absence of the 12-OH group in 26. The presence of the 6-OH group was supported by the downshifted C-6 signal (δC 71.5 CH in 26, whereas δC 33.7 CH2 in 2-O-acetyl-2-dehydroxy-12-deacetylxyloccensin U), the 1 H-1 H COSY crosspeak between H-5/H-6 and HMBC correlations between H-6/C-5 and H-6/C-7. The upshifted C-12 signal (δC 29.5, CH2 in 26, whereas δC 66.6 CH in 2-O-acetyl-2-dehydroxy-12-deacetylxyloccensin U), 1 H-1 H COSY cross-peaks between H2-11/H2-12, and HMBC correlations between H3-18/C-12 ( Figure  10a ) confirmed the absence of the 12-OH group in 26. NOE correlations between H-17/H-12β, H-12β/H-5, H-17/H-5, H-5/H-30, H3-18/H-12α, H3-18/H-11α, H3-19/Hpro-S-29, and H-3/Hpro-R-29 revealed the same relative configuration of 26 as that of 2-O-acetyl-2-dehydroxy-12-deacetylxyloccensin U (Figure 10b ). The ECD spectrum of 26 was nicely matched with that of 2-O-acetyl-2-dehydroxy-12-deacetylxyloccensin U (Figure 10c ), revealing the same absolute configuration for the two compounds. Thus, the structure of 26-named xylomolin L1-was assigned as 6-hydroxy-12-dehydroxy-2-O-acetyl-2-dehydroxy-12-deacetylxyloccensin U. (Tables 7 and 8 ) resembled those of 2-O-acetyl-2-dehydroxy-12-deacetylxyloccensin U [18] , being a phragmalin 8,9,30-ortho ester isolated from X. moluccensis, except for the presence of an additional 6-OH group and the absence of the 12-OH group in 26. The presence of the 6-OH group was supported by the downshifted C-6 signal (δ C 71.5 CH in 26, whereas δ C 33.7 CH 2 in 2-O-acetyl-2-dehydroxy-12-deacetylxyloccensin U), the 1 H-1 H COSY cross-peak between H-5/H-6 and HMBC correlations between H-6/C-5 and H-6/C-7.
The upshifted C-12 signal (δ C 29.5, CH 2 in 26, whereas δ C 66.6 CH in 2-O-acetyl-2-dehydroxy-12-deacetylxyloccensin U), 1 H-1 H COSY cross-peaks between H 2 -11/H 2 -12, and HMBC correlations between H 3 -18/C-12 (Figure 10a ) confirmed the absence of the 12-OH group in 26. NOE correlations between H-17/H-12β, H-12β/H-5, H-17/H-5, H-5/H-30, H 3 -18/H-12α, H 3 -18/H-11α, H 3 -19/H pro-S -29, and H-3/H pro-R -29 revealed the same relative configuration of 26 as that of 2-O-acetyl-2-dehydroxy-12-deacetylxyloccensin U (Figure 10b ). The ECD spectrum of 26 was nicely matched with that of 2-O-acetyl-2-dehydroxy-12-deacetylxyloccensin U (Figure 10c ), revealing the same absolute configuration for the two compounds. Thus, the structure of 26-named xylomolin L 1 -was assigned as 6-hydroxy-12-dehydroxy-2-O-acetyl-2-dehydroxy-12-deacetylxyloccensin U. The molecular formula of 27 was determined to be C34H40O13 by the positive HRESIMS ion peak at m/z 679.2374 (calcd. for [M + Na] + , 679.2361). The NMR spectroscopic data of 27 (Tables 7 and 8) closely resembled those of swietephragmin G [26] , being a phragmalin 8,9,30-ortho ester, except for the presence of an additional 12-OH group, which was supported by the downshifted C-12 signal (δC 66.5 CH in 27, whereas δC 29.2 CH2 in swietephragmin G), 1 H-1 H COSY cross-peaks between H2-11/H-12, and HMBC correlations between H3-18/C-12. The strong NOE interaction between H-17/H-12 assigned the β-oriented H-12 and the corresponding α-orientation for the 12-OH group. The NOE interaction between H3-37/H3-38 assigned the E configuration for the double bond of 3-tigloyloxy group. Therefore, the structure of 27-named xylomolin L2-was identified as 12α-hydroxyswietephragmin G.
Compound 28 had the molecular formula C28H37O6 as determined from the positive HRESIMS ion peak at m/z 469.2603 (calcd. for [M + H] + , 469.2585). The NMR spectroscopic data of 28 (Tables 7  and 8 -19, and H3-18/H-11α, H3-18/H-12α, H3-18/H-20, H3-18/H-9 , and H-9/H-5 indicated the β-orientation for H -7, H-17, H3-19, and H3-30 , and the α-orientation for H -5, H-9, H3-18, and H-20 (Figure 11b) . Hence, the relative configuration of 28-named xylomolin M-was assigned as depicted. The molecular formula of 27 was determined to be C 34 H 40 O 13 by the positive HRESIMS ion peak at m/z 679.2374 (calcd. for [M + Na] + , 679.2361). The NMR spectroscopic data of 27 (Tables 7  and 8 ) closely resembled those of swietephragmin G [26] , being a phragmalin 8,9,30-ortho ester, except for the presence of an additional 12-OH group, which was supported by the downshifted C-12 signal (δ C 66.5 CH in 27, whereas δ C 29.2 CH 2 in swietephragmin G), 1 H-1 H COSY cross-peaks between H 2 -11/H-12, and HMBC correlations between H 3 -18/C-12. The strong NOE interaction between H-17/H-12 assigned the β-oriented H-12 and the corresponding α-orientation for the 12-OH group. The NOE interaction between H 3 -37/H 3 -38 assigned the E configuration for the double bond of 3-tigloyloxy group. Therefore, the structure of 27-named xylomolin L 2 -was identified as 12α-hydroxy-swietephragmin G.
Compound 28 had the molecular formula C 28 H 37 O 6 as determined from the positive HRESIMS ion peak at m/z 469.2603 (calcd. for [M + H] + , 469.2585). The NMR spectroscopic data of 28 (Tables 7 and 8) were closely related to those of andirolide Q [27] , except for the different positions of the ester carbonyl carbon of the C-17 attached five-membered γ-lactone ring, viz. C-21 in 28 instead of C-23 in andirolide Q. Significant 1 H-1 H COSY correlations between H-17/H-20, H-20/H 2 -22, H 2 -22/H 2 -23 and the HMBC correlation between H-17/C-21 confirmed the above deduction (Figure 11a) . NOE interactions between H-17/H-12β, H-12β/H 3 -30, H 3 -30/H-7, H 3 -30/H-11β, H-11β/H 3 -19, and H 3 -18/H-11α, H 3 -18/H-12α, H 3 -18/H-20, H 3 -18/H-9 , and H-9/H-5 indicated the β-orientation for H -7, H-17, H 3 -19, and H 3 -30 , and the α-orientation for H -5, H-9, H 3 -18, and H-20 (Figure 11b) . Hence, the relative configuration of 28-named xylomolin M-was assigned as depicted. (Table S1 ) [28] . Cisplatin was used as the positive control. Compounds 11 and 23 showed weak activities against the tested cancer cell lines, whereas the other ten compounds were inactive at 100 μM. Compound 23 exhibited selective antitumor activity against human breast MD-MBA-231 cancer cells with an IC50 value of 37.7 μM.
Anti-HIV activities of 1, 3, 8, 10, 11, 14, 20, 23-25, and 27 were tested in vitro with the HIV-1 virus transfected 293 T cells [29] . At the concentration of 20 μM, 1, 11, 23, and 24 showed inhibitory rates of 17.49 ± 6.93%, 24.47 ± 5.04%, 14.77 ± 5.91%, and 14.34 ± 3.92%, respectively (Table S2) . Efavirenz was used as the positive control with an inhibitory rate of 88.54 ± 0.45% at the same concentration.
Materials and Methods

General Methods
Optical rotations were recorded on a MCP500 modular circular polarimeter (Anton Paar Opto Tec GmbH, Seelze, Germany). UV spectra were obtained on a GENESYS 10S UV-Vis spectrophotometer (Thermo Fisher Scientific, Shanghai, China). HRESIMS were measured on a Bruker maXis ESI-QTOF mass spectrometer (Bruker Daltonics, Bremen, Germany). NMR spectra were recorded on a Bruker AV-400 spectrometer with TMS as the internal standard. Single-crystal Xray diffraction analyses were made on an Agilent Xcalibur Atlas Gemini Ultra-diffractometer (Agilent Technologies, Santa Clara, CA, USA) with mirror monochromated CuKα radiation (λ = 1.54178 Å) at 150 K. Semi-preparative HPLC (Waters Corporation, Milford, MA, USA) was performed on a Waters 2535 pump equipped with a waters 2998 photodiode array detector and YMC C18 reverse-phased columns (250 mm × 10 mm i.d., 5 μm). For column chromatography, silica gel (100-200 mesh) (Qingdao Mar. Chem. Ind. Co. Ltd., Qingdao, China) and C18 reverse-phased silica gel (ODS-A-HG 12 nm, 50 μm, YMC Co. Ltd., Kyoto, Japan) were used. ECD spectra were measured on a Jasco J-810 spectropolarimeter (JASCO Corporation, Tokyo, Japan) in MeCN. (Table S1 ) [28] . Cisplatin was used as the positive control. Compounds 11 and 23 showed weak activities against the tested cancer cell lines, whereas the other ten compounds were inactive at 100 µM. Compound 23 exhibited selective antitumor activity against human breast MD-MBA-231 cancer cells with an IC 50 value of 37.7 µM.
Anti-HIV activities of 1, 3, 8, 10, 11, 14, 20, 23-25, and 27 were tested in vitro with the HIV-1 virus transfected 293 T cells [29] . At the concentration of 20 µM, 1, 11, 23, and 24 showed inhibitory rates of 17.49 ± 6.93%, 24.47 ± 5.04%, 14.77 ± 5.91%, and 14.34 ± 3.92%, respectively (Table S2) . Efavirenz was used as the positive control with an inhibitory rate of 88.54 ± 0.45% at the same concentration.
Materials and Methods
General Methods
Optical rotations were recorded on a MCP500 modular circular polarimeter (Anton Paar Opto Tec GmbH, Seelze, Germany). UV spectra were obtained on a GENESYS 10S UV-Vis spectrophotometer (Thermo Fisher Scientific, Shanghai, China). HRESIMS were measured on a Bruker maXis ESI-QTOF mass spectrometer (Bruker Daltonics, Bremen, Germany). NMR spectra were recorded on a Bruker AV-400 spectrometer with TMS as the internal standard. Single-crystal X-ray diffraction analyses were made on an Agilent Xcalibur Atlas Gemini Ultra-diffractometer (Agilent Technologies, Santa Clara, CA, USA) with mirror monochromated CuKα radiation (λ = 1.54178 Å) at 150 K. Semi-preparative HPLC (Waters Corporation, Milford, MA, USA) was performed on a Waters 2535 pump equipped with a waters 2998 photodiode array detector and YMC C18 reverse-phased columns (250 mm × 10 mm i.d., 5 µm). For column chromatography, silica gel (100-200 mesh) (Qingdao Mar. Chem. Ind. Co.
